Pharmacodynamic effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, from a randomized study in patients with type 2 diabetes.

by Sue Sha, Damayanthi Devineni, Atalanta Ghosh, David Polidori, Marcus Hompesch, Sabine Arnolds, Linda Morrow, Heike Spitzer, Keith Demarest, Paul Rothenberg
Published 2014-01-01

Pharmacodynamic effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, from a randomized study in patients with type 2 diabetes.

by Sue Sha, Damayanthi Devineni, Atalanta Ghosh, David Polidori, Marcus Hompesch, Sabine Arnolds, Linda Morrow, Heike Spitzer, Keith Demarest, Paul Rothenberg
Published 2014-01-01

Outpatient versus inpatient mixed meal tolerance and arginine stimulation testing yields comparable measures of variability for assessment of beta cell function

by Sudha S. Shankar, Douglas S. Lee, Ralph H. Raymond, Roberto A. Calle, Claudio Cobelli, Atalanta Ghosh, R. Paul Robertson, Hartmut Ruetten, Myrlene A. Staten, Darko Stefanovski, Adrian Vella, Sanya Whitaker, David A. Fryburg
Published 2018-06-01